Synthetic peptide inhibit toxicity, aggregation of protein in Alzheimer’s disease, in a new study: The synthetic peptides block amyloid beta aggregation at the early and most toxic stage when oligomers form, in human neural cells grown in culture, and in two laboratory animal models for Alzheimer’s.

See the source article by following the link below:
Synthetic peptide inhibit toxicity, aggregation of protein in Alzheimer’s disease, in a new study: The synthetic peptides block amyloid beta aggregation at the early and most toxic stage when oligomers form, in human neural cells grown in culture, and in two laboratory animal models for Alzheimer’s.